{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T20:32:50Z","timestamp":1784838770347,"version":"3.55.0"},"reference-count":57,"publisher":"MDPI AG","issue":"4","license":[{"start":{"date-parts":[[2025,2,12]],"date-time":"2025-02-12T00:00:00Z","timestamp":1739318400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"European Union\u2019s H2020 research grant","award":["801586"],"award-info":[{"award-number":["801586"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecules"],"abstract":"<jats:p>Nowadays, the diagnosis of Parkinson\u2019s disease (PD) remains essentially clinical, based on the subjective observations of clinicians. In addition, misdiagnosis with other neuro disorders, such as Alzheimer\u2019s (AD), can occur. Herein, an untargeted lipidomic analysis of 75 plasma samples was performed to identify lipid species capable of discriminating between these two neuro groups. Therefore, PLS-DA and OPLS-DA analysis revealed significant differences in patient profiles in the sphingolipid and glycerophospholipid categories. As a result, a putative lipid biomarker panel was developed, which included HexCer (40:1; O2) and PC (O-32:0), with an area under the receiver operating characteristic curve (AUC) &gt; 80, respectively. This panel was effective in discriminating between diseased and healthy subjects, but most importantly, it could discriminate between two neurodegenerative disorders that can present similar symptoms, namely PD and AD. Together, these findings suggest that the dysregulated metabolism of lipids plays a critical role in AD and PD pathology and may represent a valuable clinical tool for their diagnosis. Thus, further targeted studies are encouraged to better understand the underlying mechanisms of PD and confirm the diagnostic potency of the identified lipid metabolites.<\/jats:p>","DOI":"10.3390\/molecules30040850","type":"journal-article","created":{"date-parts":[[2025,2,12]],"date-time":"2025-02-12T12:12:16Z","timestamp":1739362336000},"page":"850","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Untargeted Lipidomic Reveals Potential Biomarkers in Plasma Samples for the Discrimination of Patients Affected by Parkinson\u2019s Disease"],"prefix":"10.3390","volume":"30","author":[{"given":"Kateryna","family":"Tkachenko","sequence":"first","affiliation":[{"name":"Department of Chemistry, University of La Rioja, 26006 Logro\u00f1o, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4463-8343","authenticated-orcid":false,"given":"Jose Mar\u00eda","family":"Gonz\u00e1lez-S\u00e1iz","sequence":"additional","affiliation":[{"name":"Department of Chemistry, University of La Rioja, 26006 Logro\u00f1o, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6450-8741","authenticated-orcid":false,"given":"Consuelo","family":"Pizarro","sequence":"additional","affiliation":[{"name":"Department of Chemistry, University of La Rioja, 26006 Logro\u00f1o, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,2,12]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/S1474-4422(18)30295-3","article-title":"Global, Regional, and National Burden of Parkinson\u2019s Disease, 1990\u20132016: A Systematic Analysis for the Global Burden of Disease Study 2016","volume":"17","author":"Elbaz","year":"2018","journal-title":"Lancet Neurol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s12264-019-00433-1","article-title":"Biomarkers for Parkinson\u2019s Disease: How Good Are They?","volume":"36","author":"Li","year":"2020","journal-title":"Neurosci. Bull."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/978-94-007-5416-4_16","article-title":"Parkinson\u2019s Disease","volume":"65","author":"Mhyre","year":"2012","journal-title":"Subcell. Biochem."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s40120-018-0122-z","article-title":"Emerging Immunotherapies for Parkinson Disease","volume":"8","author":"Zella","year":"2019","journal-title":"Neurol. Ther."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S1474-4422(19)30024-9","article-title":"CSF and Blood Biomarkers for Parkinson\u2019s Disease","volume":"18","author":"Parnetti","year":"2019","journal-title":"Lancet Neurol."},{"key":"ref_6","first-page":"525","article-title":"Epidemiology of Parkinson\u2019s Disease Epidemiology of Parkinson\u2019s Disease","volume":"5","author":"Alves","year":"2008","journal-title":"J. Neurol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1212\/WNL.0000000000002350","article-title":"Accuracy of Clinical Diagnosis of Parkinson Disease","volume":"86","author":"Rizzo","year":"2016","journal-title":"Neurology"},{"key":"ref_8","first-page":"631","article-title":"Uncovering Important Diagnostic Features for Alzheimer\u2019s, Parkinson\u2019s and Other Dementias Using. Interpretable Association Mining Methods","volume":"30","author":"Noshin","year":"2025","journal-title":"HHS Public Access"},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Wang, J., Li, X., Pang, H., Bu, S., Zhao, M., Liu, Y., Yu, H., Jiang, Y., and Fan, G. Differential Connectivity Patterns of Mild Cognitive Impairment in Alzheimer\u2019s and Parkinson\u2019s Disease: A Large-Scale Brain Network Study. Acad. Radiol., 2025. in press.","DOI":"10.1016\/j.acra.2024.09.017"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"100932","DOI":"10.1016\/j.bbih.2024.100932","article-title":"The Role of CXCL12\/CXCR4\/CXCR7 Axis in Cognitive Impairment Associated with Neurodegenerative Diseases","volume":"43","author":"Sarallah","year":"2025","journal-title":"Brain Behav. Immun. Health"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1089\/ars.2015.6343","article-title":"Alpha-Synuclein Oligomers Interact with Metal Ions to Induce Oxidative Stress and Neuronal Death in Parkinson\u2019s Disease","volume":"24","author":"Deas","year":"2016","journal-title":"Antioxid. Redox Signal"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"e8502","DOI":"10.1097\/MD.0000000000008502","article-title":"The Significance of Uric Acid in the Diagnosis and Treatment of Parkinson Disease","volume":"96","author":"Yu","year":"2017","journal-title":"Medicine"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"110766","DOI":"10.1016\/j.exger.2019.110766","article-title":"Circulating Amino Acid Signature in Older People with Parkinson\u2019s Disease: A Metabolic Complement to the EXosomes in PArkiNson Disease (EXPAND) Study","volume":"128","author":"Picca","year":"2019","journal-title":"Exp. Gerontol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1007\/s12035-014-8661-5","article-title":"Lipid Integration in Neurodegeneration: An Overview of Alzheimer\u2019s Disease","volume":"50","author":"Yadav","year":"2014","journal-title":"Mol. Neurobiol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1002\/mds.25729","article-title":"Altered Ceramide Acyl Chain Length and Ceramide Synthase Gene Expression in Parkinson\u2019s Disease","volume":"29","author":"Abbott","year":"2014","journal-title":"Mov. Disord."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1042\/EBC20210026","article-title":"Membrane Lipid Raft Homeostasis Is Directly Linked to Neurodegeneration","volume":"65","author":"Moll","year":"2021","journal-title":"Essays Biochem."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"537","DOI":"10.3233\/JAD-2011-111202","article-title":"Increased Ceramide in Brains with Alzheimer\u2019s and Other Neurodegenerative Diseases","volume":"29","author":"Filippov","year":"2012","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Huo, Z., Rana, B.K., Elman, J.A., Dong, R., Engelman, C.D., Johnson, S.C., Lyons, M.J., Franz, C.E., Kremen, W.S., and Zhao, J. (2020). Metabolic Profiling of Cognitive Aging in Midlife. Front. Aging Neurosci., 12.","DOI":"10.3389\/fnagi.2020.555850"},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Nicholls, A., Theodoridis, G., and Wilson, I.D. (2014). Global Metabolic Profiling in Health and Disease. Global Metabolic Profiling: Clinical Application, Future Science Ltd.","DOI":"10.4155\/ebo.13.339"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1002\/mds.27173","article-title":"Profiling Novel Metabolic Biomarkers for Parkinson\u2019s Disease Using In-depth Metabolomic Analysis","volume":"32","author":"Han","year":"2017","journal-title":"Mov. Disord."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s13024-018-0304-2","article-title":"Recent Advances and Perspectives of Metabolomics-Based Investigations in Parkinson\u2019s Disease","volume":"14","author":"Shao","year":"2019","journal-title":"Mol. Neurodegener."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.jprot.2014.01.014","article-title":"Combination of Metabolomic and Phospholipid-Profiling Approaches for the Study of Alzheimer\u2019s Disease","volume":"104","year":"2014","journal-title":"J. Proteom."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Pe\u00f1a-Bautista, C., \u00c1lvarez-S\u00e1nchez, L., Roca, M., Garc\u00eda-Vall\u00e9s, L., Baquero, M., and Ch\u00e1fer-Peric\u00e1s, C. (2022). Plasma Lipidomics Approach in Early and Specific Alzheimer\u2019s Disease Diagnosis. J. Clin. Med., 11.","DOI":"10.3390\/jcm11175030"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/j.jalz.2015.12.008","article-title":"Blood Metabolite Markers of Preclinical Alzheimer\u2019s Disease in Two Longitudinally Followed Cohorts of Older Individuals","volume":"12","author":"Casanova","year":"2016","journal-title":"Alzheimer\u2019s Dement."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"9979","DOI":"10.1039\/D2CC03598G","article-title":"Addressing Big Data Challenges in Mass Spectrometry-Based Metabolomics","volume":"58","author":"Guo","year":"2022","journal-title":"Chem. Commun."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Han, X. (2016). Lipidomics: Comprehensive Mass Spectrometry of Lipids, John Wiley & Sons.","DOI":"10.1002\/9781119085263"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"e12","DOI":"10.1186\/s40169-018-0190-9","article-title":"Clinical Lipidomics: A New Way to Diagnose Human Diseases","volume":"7","author":"Lv","year":"2018","journal-title":"Clin. Transl. Med."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"12085","DOI":"10.1021\/ac403181c","article-title":"Plasma Lipidomic Profiling Method Based on Ultrasound Extraction and Liquid Chromatography Mass Spectrometry","volume":"85","author":"Pizarro","year":"2013","journal-title":"Anal. Chem."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"W388","DOI":"10.1093\/nar\/gkab382","article-title":"MetaboAnalyst 5.0: Narrowing the Gap between Raw Spectra and Functional Insights","volume":"49","author":"Pang","year":"2021","journal-title":"Nucleic Acids Res"},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Cruciani-Guglielmacci, C., L\u00f3pez, M., Campana, M., and le Stunff, H. (2017). Brain Ceramide Metabolism in the Control of Energy Balance. Front. Physiol., 8.","DOI":"10.3389\/fphys.2017.00787"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.jbior.2018.09.013","article-title":"Sphingolipids in Neurodegeneration (with Focus on Ceramide and S1P)","volume":"70","author":"Wang","year":"2018","journal-title":"Adv. Biol. Regul."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.plipres.2014.01.004","article-title":"Ceramide: A Simple Sphingolipid with Unique Biophysical Properties","volume":"54","author":"Castro","year":"2014","journal-title":"Prog. Lipid Res."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/nm.3466","article-title":"Plasma Phospholipids Identify Antecedent Memory Impairment in Older Adults","volume":"20","author":"Mapstone","year":"2014","journal-title":"Nat. Med."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"809","DOI":"10.3233\/JAD-160645","article-title":"Association between Plasma Ceramides and Phosphatidylcholines and Hippocampal Brain Volume in Late Onset Alzheimer\u2019s Disease","volume":"60","author":"Kim","year":"2017","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"4829180","DOI":"10.1155\/2017\/4829180","article-title":"Ethanolamine and Phosphatidylethanolamine: Partners in Health and Disease","volume":"2017","author":"Patel","year":"2017","journal-title":"Oxid. Med. Cell Longev."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"23","DOI":"10.2174\/1568005310303010023","article-title":"Unfolding the Pathophysiological Role of Bioactive Lysophospholipids","volume":"3","author":"Xu","year":"2003","journal-title":"Curr. Drug Targets Immune Endocr. Metab. Disord."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1007\/s11357-022-00548-w","article-title":"Longitudinal Associations between Blood Lysophosphatidylcholines and Skeletal Muscle Mitochondrial Function","volume":"44","author":"Tian","year":"2022","journal-title":"Geroscience"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.biochi.2012.10.009","article-title":"Novel Bioactive Glycerol-Based Lysophospholipids: New Data-New Insight into Their Function","volume":"95","author":"Grzelczyk","year":"2013","journal-title":"Biochimie"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s40035-022-00322-0","article-title":"Deciphering Lipid Dysregulation in ALS: From Mechanisms to Translational Medicine","volume":"11","author":"Agrawal","year":"2022","journal-title":"Transl. Neurodegener."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"e8595","DOI":"10.1002\/rcm.8595","article-title":"Increased Plasma Phosphatidylcholine\/Lysophosphatidylcholine Ratios in Patients with Parkinson\u2019s Disease","volume":"34","author":"Schiller","year":"2020","journal-title":"Rapid Commun. Mass. Spectrom."},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"L\u00f3pez de Frutos, L., Almeida, F., Murillo-Saich, J., Concei\u00e7\u00e3o, V.A., Guma, M., Queheberger, O., Giraldo, P., and Miltenberger-Miltenyi, G. (2022). Serum Phospholipid Profile Changes in Gaucher Disease and Parkinson\u2019s Disease. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms231810387"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.semcdb.2021.02.003","article-title":"Lipids: Key Players in Central Nervous System Cell Physiology and Pathology","volume":"112","author":"Ngo","year":"2021","journal-title":"Semin. Cell Dev. Biol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1194\/jlr.E400004-JLR200","article-title":"A Comprehensive Classification System for Lipids","volume":"46","author":"Fahy","year":"2005","journal-title":"J. Lipid Res."},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Schmitt, F., Hussain, G., Dupuis, L., Loeffler, J.P., and Henriques, A. (2014). A Plural Role for Lipids in Motor Neuron Diseases: Energy, Signaling and Structure. Front. Cell Neurosci., 8.","DOI":"10.3389\/fncel.2014.00025"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"667","DOI":"10.3233\/JAD-220349","article-title":"Cerebrospinal Fluid Sphingomyelins in Alzheimer\u2019s Disease, Neurodegeneration, and Neuroinflammation","volume":"90","author":"Morrow","year":"2022","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Baloni, P., Arnold, M., Buitrago, L., Nho, K., Moreno, H., Huynh, K., Brauner, B., Louie, G., Kueider-Paisley, A., and Suhre, K. (2022). Multi-Omic Analyses Characterize the Ceramide\/Sphingomyelin Pathway as a Therapeutic Target in Alzheimer\u2019s Disease. Commun. Biol., 5.","DOI":"10.1101\/2021.07.16.21260601"},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Custodia, A., Aramburu-N\u00fa\u00f1ez, M., Correa-Paz, C., Posado-Fern\u00e1ndez, A., G\u00f3mez-Larrauri, A., Castillo, J., G\u00f3mez-Mu\u00f1oz, A., Sobrino, T., and Ouro, A. (2021). Ceramide Metabolism and Parkinson\u2019s Disease\u2014Therapeutic Targets. Biomolecules, 11.","DOI":"10.3390\/biom11070945"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/jnc.15044","article-title":"Role of Sphingolipid Metabolism in Neurodegeneration","volume":"158","author":"Alaamery","year":"2021","journal-title":"J. Neurochem."},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Estes, R.E., Lin, B., Khera, A., and Davis, M.Y. (2021). Lipid Metabolism Influence on Neurodegenerative Disease Progression: Is the Vehicle as Important as the Cargo?. Front. Mol. Neurosci., 14.","DOI":"10.3389\/fnmol.2021.788695"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.parkreldis.2017.08.026","article-title":"Serum Lipid Alterations in GBA-Associated Parkinson\u2019s Disease","volume":"44","author":"Guedes","year":"2017","journal-title":"Park. Relat. Disord."},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Plotegher, N., Bubacco, L., Greggio, E., and Civiero, L. (2019). Ceramides in Parkinson\u2019s Disease: From Recent Evidence to New Hypotheses. Front. Neurosci., 13.","DOI":"10.3389\/fnins.2019.00330"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1007\/s11064-007-9297-x","article-title":"Gene Expression Alterations in the Sphingolipid Metabolism Pathways during Progression of Dementia and Alzheimer\u2019s Disease: A Shift toward Ceramide Accumulation at the Earliest Recognizable Stages of Alzheimer\u2019s Disease?","volume":"32","author":"Katsel","year":"2007","journal-title":"Neurochem. Res."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jchromb.2018.02.039","article-title":"Determination of Acetyl Coenzyme A in Human Whole Blood by Ultra-Performance Liquid Chromatography-Mass Spectrometry","volume":"1083","author":"Speziale","year":"2018","journal-title":"J. Chromatogr. B"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"e47866","DOI":"10.7554\/eLife.47866","article-title":"Elevating Acetyl-CoA Levels Reduces Aspects of Brain Aging","volume":"8","author":"Currais","year":"2019","journal-title":"Elife"},{"key":"ref_55","doi-asserted-by":"crossref","unstructured":"Hu, L., Huang, Y.-J., Wei, Y.-D., Li, T., Ke, W., Chen, G.-H., and Dong, M.-X. (2024). Plasma Metabolomics Profiles Indicate Sex Differences of Lipid Metabolism in Patients with Parkinson\u2019s Disease. Sci. Rep., 14.","DOI":"10.1038\/s41598-024-82674-3"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.molmed.2013.01.002","article-title":"Shared Dysregulated Pathways Lead to Parkinson\u2019s Disease and Diabetes","volume":"19","author":"Santiago","year":"2013","journal-title":"Trends Mol. Med."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1186\/s12933-021-01421-4","article-title":"Effect of Blood Lipid Variability on Mortality in Patients with Type 2 Diabetes: A Large Single-Center Cohort Study","volume":"20","author":"Wang","year":"2021","journal-title":"Cardiovasc. Diabetol."}],"container-title":["Molecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1420-3049\/30\/4\/850\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T16:32:22Z","timestamp":1760027542000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1420-3049\/30\/4\/850"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,12]]},"references-count":57,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2025,2]]}},"alternative-id":["molecules30040850"],"URL":"https:\/\/doi.org\/10.3390\/molecules30040850","relation":{},"ISSN":["1420-3049"],"issn-type":[{"value":"1420-3049","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,12]]}}}